This protocol will determine the anti-tumor activity of a 72-hour every 2 week infusion of 9-aminocamptothecin plus G-CSF in extensive disease, small cell lung cancer which is either chemotherapy-naive or in first relapse after the administration of one prior chemotherapy regimen. This study will look at the toxicity and the pharmacokinetic behavior in each patient.
Showing the most recent 10 out of 565 publications